RESUMO
BACKGROUND: Alzheimer's disease (AD) involves impairment of Aß clearance. Neprilysin (NEP) is the most efficient Aß peptidase. Enhancement of the activity or expression of NEP may provide a prominent therapeutic strategy against AD. AIMS: Ten hydroxylated monocarbonyl curcumin derivatives were designed, synthesized and evaluated for their NEP upregulating potential using sensitive fluorescence-based Aß digestion and inhibition assays. RESULTS: Compound 4 was the most active one, resulting in a 50% increase in Aß cleavage activity. Cyclohexanone-bearing derivatives exhibited higher activity enhancement compared to their acetone counterparts. Inhibition experiments with the NEP-specific inhibitor thiorphan resulted in dramatic cleavage reduction. Conclusion: The increased Aß cleavage activity and the ease of synthesis of 4 renders it an extremely attractive lead compound.